The estimated Net Worth of David V Elkins is at least $32.1 millió dollars as of 10 March 2024. Mr. Elkins owns over 64,326 units of Bristol-Myers Squibb Co stock worth over $10,938,143 and over the last 15 years he sold BMY stock worth over $16,766,543. In addition, he makes $4,371,550 as Executive Vice President and Chief Financial Officer Member of the Leadership Team at Bristol-Myers Squibb Co.
David has made over 22 trades of the Bristol-Myers Squibb Co stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 64,326 units of BMY stock worth $3,125,600 on 10 March 2024.
The largest trade he's ever made was selling 133,951 units of Bristol-Myers Squibb Co stock on 13 September 2022 worth over $9,550,706. On average, David trades about 19,814 units every 112 days since 2009. As of 10 March 2024 he still owns at least 225,111 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Elkins stock trades at the bottom of the page.
David V. Elkins serves as Executive Vice President and Chief Financial Officer Member of the Leadership Team of the Company. 2014 to 2017 – Group Vice President and Chief Financial Officer, Consumer and Consumer Medicines, Johnson & Johnson 2017 to 2018 – Worldwide Vice President and Chief Financial Officer, Consumer Products, Medical Development and Corporate Functions, Johnson & Johnson 2018 to 2019 – Chief Financial Officer, Celgene 2019 to present – Executive Vice President and Chief Financial Officer
As the Executive Vice President and Chief Financial Officer Member of the Leadership Team of Bristol-Myers Squibb Co, the total compensation of David Elkins at Bristol-Myers Squibb Co is $4,371,550. There are 4 executives at Bristol-Myers Squibb Co getting paid more, with Giovanni Caforio having the highest compensation of $18,767,300.
David Elkins is 51, he's been the Executive Vice President and Chief Financial Officer Member of the Leadership Team of Bristol-Myers Squibb Co since 2019. There are 30 older and 4 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
David's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius és Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: